Filed before 2025Filed 3 October 2023
ENB Therapeutics, Inc. raised $225K
ENB Therapeutics, Inc., a biotech company based in New York, NY, raised $225K in a new debt round, according to a filing dated 3 October 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 October 2023
- Round
- Debt round
- Amount sold
- $225K
- Offering size
- $1M
- Investors so far
- 3
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 3% of the 1,396 tracked raises with an amount filed in 2023, and than 3% of the 142 in biotech.
ENB Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 3 Oct 2023 | New filing | $225K | This raise |
More with Remiges BioPharma on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.